Cargando…
Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
Human REV7 (also known as MAD2L2 and MAD2B) is involved in DNA repair, cell cycle regulation, gene transcription, and carcinogenesis. In this study, we evaluated the expression of REV7 in epithelial ovarian cancer (EOC) and analyzed the association between its expression and chemosensitivity in ovar...
Autores principales: | Niimi, Kaoru, Murakumo, Yoshiki, Watanabe, Naoki, Kato, Takuya, Mii, Shinji, Enomoto, Atsushi, Asai, Masato, Asai, Naoya, Yamamoto, Eiko, Kajiyama, Hiroaki, Shibata, Kiyosumi, Kikkawa, Fumitaka, Takahashi, Masahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317831/ https://www.ncbi.nlm.nih.gov/pubmed/24597627 http://dx.doi.org/10.1111/cas.12390 |
Ejemplares similares
-
Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012) -
Suppression of skin tumorigenesis in CD109-deficient mice
por: Sunagawa, Masaki, et al.
Publicado: (2016) -
Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology
por: Kajiyama, Hiroaki, et al.
Publicado: (2014) -
KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear-cell carcinoma cells
por: Kawai, Yosuke, et al.
Publicado: (2018) -
Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
por: Sakata, Jun, et al.
Publicado: (2017)